TICKERNERD
Menu
PACSPACSHealthcare · Medical Care Facilities

PACS Stock Forecast: PACS Group, Inc. Price Predictions for 2026-2027

Last close, 14 Oct 2026
$45
+1.35% on the day

The 6 Wall Street analysts covering PACS Group, Inc. hold a median 12-month price target of $59 — +31.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 88 of 100 as at 14 Oct 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$7.0B
Ticker Nerd rank
88 / 100
Median analyst target
$59
Analysts covering
6
Revenue$1.4B+9.1% y/y
Operating income$109.3M
Net income$76.3M
Free cash flow$4.7M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+4.1%
1M
+1.0%
YTD
+17.2%
1Y
+251.4%
From 52W high
−7.2%
From 52W low
+325.1%
$11
$48
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

PACS stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores PACS Group, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 14 Oct 2026
88 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum
99
Revisions
93
Growth
86
Issuance
83
Accruals
64
Value
61
Quality
44
Volatility
18
Size
18

Momentum (99): The shares have been drifting up relative to others.

Volatility (18): The share price moves around a lot.

Size (18): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

PACS stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on PACS, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$20$30$40$50$60Jan 26Apr 26Jul 26Oct 26PACSHigh $62Median $59Low $57

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says6 analysts
6 Buy0 Hold0 Sell
Low $57Median $59High $62

The green dot is the last close — the median target sits +31.2% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 6 moved their price target up and 1 moved it down.

DateFirmActionRatingTarget
4 Sept 2026JP MorganMaintainsOverweight$47 → $58
4 Sept 2026JP MorganMaintainsOverweight—
10 Aug 2026OppenheimerMaintainsOutperform$48 → $57
10 Aug 2026OppenheimerMaintainsOutperform—
6 Aug 2026RBC CapitalMaintainsOutperform$52 → $57
6 Aug 2026RBC CapitalMaintainsOutperform—
6 Aug 2026Truist SecuritiesMaintainsBuy$52 → $62
6 Aug 2026Truist SecuritiesMaintainsBuy—
6 Aug 2026UBSMaintainsBuy—
6 Aug 2026UBSMaintainsBuy$57 → $60
8 July 2026UBSMaintainsBuy—
8 July 2026UBSMaintainsBuy$50 → $57
18 May 2026Truist SecuritiesMaintainsBuy—
13 May 2026OppenheimerMaintainsOutperform—
4 Mar 2026OppenheimerMaintainsOutperform—
4 Mar 2026UBSMaintainsBuy—
27 Feb 2026RBC CapitalMaintainsOutperform—
18 Dec 2025UBSReinstatesBuy$50 → $42
17 Dec 2025JP MorganReinstatesOverweight$44
20 Nov 2025RBC CapitalMaintainsOutperform—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. PACS appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

PACS vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 14 Oct 2026, PACS Group, Inc. returned +251.4% against +17.5% for the S&P 500, dividends included.

PACS vs S&P 500, last 12 monthsTotal return, rebased to 100
50100150200250300350400Jan 26Apr 26Jul 26Oct 26PACSS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

PACS analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+7.8%
Analysts raising
4
Analysts cutting
0
Fundamentals

PACS Group, Inc. (PACS) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
26.5×

Cheaper than 28% of US stocks

Price / sales
1.3×

Cheaper than 63% of US stocks

Price / book
6.3×

Cheaper than 15% of US stocks

EV / EBITDA
21.4×

Cheaper than 14% of US stocks

Growth & margins
Revenue growth (YoY)
9.1%

Higher than 49% of US stocks

Earnings growth (YoY)
49.9%

Higher than 74% of US stocks

Gross margin
17.1%

Higher than 17% of US stocks

Operating margin
7.7%

Higher than 60% of US stocks

Net margin
4.8%

Higher than 60% of US stocks

Returns & dividend
Return on equity
27.9%

Higher than 87% of US stocks

Return on assets
4.6%

Higher than 74% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

PACS Group, Inc. (PACS) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • PACS Group, Inc. has a market value of $7.0B and an enterprise value of $10.3B.

  • Revenue in the twelve months to 30 June 2026: $5.6B. The latest quarter grew 9.1% year on year.

  • Net income over the same four quarters: $269.1M, a 4.8% net margin.

  • Free cash flow in the twelve months to 30 June 2026: $121.5M.

  • Shares outstanding: 158.3M.

  • Trailing P/E: 26.5×; forward P/E: 16.2× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • PACS Group, Inc. employs 47,455 people — $117K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 13 Oct 2026

Data provided by Twelve Data

Peers

PACS vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
PACSPACS Group, Inc.$7.0B
88
CHEChemed Corp.$6.9B
82
ENSGThe Ensign Group, Inc.$10.2B
61
OPCHOption Care Health, Inc.$4.9B
85
LFSTLifestance Health Group, Inc.$4.9B
94
CONConcentra Group Holdings Parent, Inc.$4.8B
96
UHSUniversal Health Services, Inc.$11.0B
69

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own PACS Group, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest PACS news & analysis

Omega to Transition Operations of 32 Facilities in Florida to PACS Group

Business Wire · 5 Oct 2026positive

Omega Healthcare Investors transitioned operations of 32 skilled nursing facilities in Florida from Airamid Health Services affiliates to PACS Group subsidiaries, effective October 1, 2026. Rent on the portfolio is scheduled to increase by $26.1 million in year one.

Why it matters — This expands PACS Group's operating portfolio by 32 skilled nursing facilities in Florida, growing its footprint and base of operations.

Seventeen PACS Post-Acute Locations Named Top Nursing Homes for 2027 by Newsweek Magazine

Business Wire · 30 Sept 2026positive

PACS Group, Inc. announced that 17 of its post-acute communities have been named by Newsweek Magazine to its list of Best Nursing Homes for 2027. The recognized communities span multiple states and are listed by their state and ranking in their respective size categories.

Why it matters — The recognition of 17 PACS post-acute communities by Newsweek reflects external acknowledgment of the quality of its facilities, which a PACS watcher would note as a meaningful validation.

Did PACS Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

PRNewsWire · 26 Sept 2026negative

A legal firm is reaching out to shareholders of PACS Group, Inc., alleging that company insiders may have breached their fiduciary duties. The firm encourages shareholders to contact them at no cost to discuss their rights and options, offering to handle any matter on a contingent fee basis.

Why it matters — PACS watchers would care because the firm's outreach signals potential shareholder litigation concerning insider conduct at the company.

PACS Group Announces Chief Legal Officer Transition

Business Wire · 21 Sept 2026neutral

PACS Group announced that John Mitchell retired from his role as Chief Legal Officer and Corporate Secretary, effective September 18, 2026, and will continue as a consultant to support the leadership transition. Patrick J. Murphy has been selected to succeed Mitchell as Chief Legal Officer and Corporate Secretary, effective September 21, 2026.

Why it matters — A C-suite legal leadership transition, with a consultant retained for continuity, is relevant to PACS watchers evaluating corporate governance and executive succession.

PACS Group, Inc. to Present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15, 2026

Business Wire · 14 Sept 2026neutral

PACS Group, Inc. announced that it will present at the 2026 Jefferies Healthcare Services and Technology Conference on September 15, 2026, in Nashville, TN. CEO and Chairman Jason Murray, CFO Carey Hendrickson, and COO Josh Jergensen will present on the Company's operations, growth strategy, and related information.

Why it matters — A PACS watcher would care because the presentation gives investors exposure to the Company's leadership discussing its operations and growth strategy at a major industry conference.

FAQ

Frequently asked questions about PACS stock

What is the PACS stock price forecast for 2026-2027?

The 6 Wall Street analysts covering PACS Group, Inc. have a median 12-month price target of $59, with estimates ranging from $57 to $62. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is PACS stock a buy right now?

Of the 6 analysts covering PACS Group, Inc., 6 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks PACS Group, Inc. 88 out of 100 across roughly 4,600 US stocks as at 14 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank PACS?

As at 14 Oct 2026, PACS Group, Inc. ranks 88 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (99 of 100).

Will PACS stock go up?

No one can know that. What the data says: the median 12-month target from 6 analysts implies +31.2% from the last close, and Ticker Nerd's factor model ranks PACS Group, Inc. 88 out of 100 as at 14 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the PACS stock forecast for 2030?

No analyst covering PACS Group, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for PACS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $57 to $62 over the next 12 months.

How has PACS stock performed over the past year?

PACS Group, Inc. returned +251.4% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does PACS Group, Inc. do?

PACS Group, Inc. is a healthcare holding company focused on post-acute care services in the United States.

What is the latest news on PACS?

The most recent item we track (Business Wire, 5 Oct 2026): "Omega to Transition Operations of 32 Facilities in Florida to PACS Group". Omega Healthcare Investors transitioned operations of 32 skilled nursing facilities in Florida from Airamid Health Services affiliates to PACS Group subsidiaries, effective October 1, 2026. Rent on the portfolio is scheduled to increase by $26.1 million in year one.

Company

About PACS Group, Inc.

PACS Group, Inc. is a healthcare holding company focused on post-acute care services in the United States. Through its subsidiaries, PACS Group operates skilled nursing facilities, assisted living communities, and independent living services, while also supporting care delivery with administrative, technology, training, and compliance functions. The company’s portfolio serves patients and residents who need rehabilitation, long-term support, or daily living assistance after hospital stays or as part of ongoing senior care. PACS Group also participates in the acquisition, ownership, and leasing of health care-related properties, giving it a role in both care operations and facility infrastructure. Based in Salt Lake City, Utah, PACS Group is positioned as a national platform in the post-acute and senior living markets.

CEO Mr. Jason Murray · 47,455 employees · United States · https://pacs.com